In yesterday’s Wall Street session, Teladoc Health Inc (NYSE:TDOC) shares traded at $18.96, up 2.43% from the previous session.
As of this writing, 26 analysts cover Teladoc Health Inc (NYSE:TDOC). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $34.00 and a low of $16.00, we find $21.50. Given the previous closing price of $18.51, this indicates a potential upside of 16.15 percent. TDOC stock price is now 6.87% away from the 50-day moving average and -17.26% away from the 200-day moving average. The market capitalization of the company currently stands at $3.14B.
There are 20 analysts who have given it a hold rating, whereas 6 have given it a buy rating. Brokers who have rated the stock have averaged $22.61 as their price target over the next twelve months.
With the price target of $25, Stephens recently initiated with Equal-Weight rating for Teladoc Health Inc (NYSE: TDOC).
In other news, Murthy Mala, CHIEF FINANCIAL OFFICER sold 3,004 shares of the company’s stock on Dec 04. The stock was sold for $56,782 at an average price of $18.90. Upon completion of the transaction, the CHIEF FINANCIAL OFFICER now directly owns 49,315 shares in the company, valued at $0.94 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 04, CHIEF EXECUTIVE OFFICER GOREVIC JASON N sold 2,877 shares of the business’s stock. A total of $54,381 was realized by selling the stock at an average price of $18.90. This leaves the insider owning 601,734 shares of the company worth $11.41 million. Insiders disposed of 239,010 shares of company stock worth roughly $4.53 million over the past 1 year. A total of 0.81% of the company’s stock is owned by insiders.
Wednesday morning saw Teladoc Health Inc (NYSE: TDOC) opened at $18.74. During the past 12 months, Teladoc Health Inc has had a low of $15.02 and a high of $34.36. As of last week, the company has a debt-to-equity ratio of 0.69, a current ratio of 3.37, and a quick ratio of 3.28. The fifty day moving average price for TDOC is $17.74 and a two-hundred day moving average price translates $22.91 for the stock.
The latest earnings results from Teladoc Health Inc (NYSE: TDOC) was released for Sep, 2023. According to the Health Information Services Company, earnings per share came in at -$0.35, beating analysts’ expectations of -$0.37 by 0.02. This compares to -$0.45 EPS in the same period last year. The net profit margin was -155.12% and return on equity was -95.88% for TDOC. The company reported revenue of $660.24 million for the quarter, compared to $611.4 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.99 percent. For the current quarter, analysts expect TDOC to generate $671.36M in revenue.
Teladoc Health Inc(TDOC) Company Profile
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its that licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
